Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05287841 · ClinicalTrials.gov registry record · NA
Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction?
A NA study of Allergic Rhinitis and Nasal Polyps, sponsored by Northwell Health.
- Recruiting
- Registry status
- NA
- Development phase
- 96
- Enrollment target
- 3
- Study locations
NCT05287841 is a NA study of Allergic Rhinitis and Nasal Polyps that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 96 participants, roughly in line with the 101-participant average among 23 other Allergic Rhinitis trials with a reported enrollment target. The trial reports 3 study locations across 2 states.
The verdict
NCT05287841, a NA study of Allergic Rhinitis and Nasal Polyps, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
- 3
- Study locations
Study Summary
The objective of this study is to compare the effectiveness of batten grafts plus septoplasty and turbinate reduction (intervention arm) compared to septoplasty and turbinate reduction alone (control arm), both in terms of subjective and objective assessments.
Conditions Studied
Interventions
- PROCEDURE Batten batten graft
- PROCEDURE Septoplasty
- PROCEDURE Inferior Turbinate Reduction
Study Locations (3)
New York
- Lenox Hill Hospital/Staten Island University Hospital - New York
- Staten Island University Hospital - Staten Island
Missouri
- Poplar Bluff Regional Medical Center - Poplar Bluff
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2021-04-30 |
| Est. Completion | 2025-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05287841
The ClinicalTrials.gov registry entry for NCT05287841 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 101-participant average among 23 other Allergic Rhinitis trials with a reported enrollment target. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Allergic Rhinitis appearing as the primary indexed condition, and to 3 interventions - of which Batten batten graft is the first listed.
NCT05287841 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New York, Missouri.
Frequently Asked Questions
What is clinical trial NCT05287841 about?
NCT05287841 is a clinical study titled "Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction?". The objective of this study is to compare the effectiveness of batten grafts plus septoplasty and turbinate reduction (intervention arm) compared to septoplasty and turbinate reduction alone (control arm), both in terms of subjective and objective assessments.
What is the current status of trial NCT05287841?
This trial is currently recruiting. It is a NA study. The enrollment target is 96 participants. The study started on 2021-04-30. Estimated completion is 2025-06-15.
What conditions does trial NCT05287841 study?
This clinical trial studies the following conditions: Allergic Rhinitis, Nasal Polyps, Nasal Obstruction, Nasal Valve Collapse, Septal Defect.
What interventions are being tested in trial NCT05287841?
The interventions under investigation include: Batten batten graft (PROCEDURE), Septoplasty (PROCEDURE), Inferior Turbinate Reduction (PROCEDURE).
Who is sponsoring clinical trial NCT05287841?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05287841 being conducted?
This trial has 3 study locations across Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Allergic Rhinitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect of Omalizumab on Responses to Cat Allergen Challenge
COMPLETED · NA
-
Effects of Diesel Exhaust Followed by Administration of Nasal Spray Flu Vaccine on Individuals With & Without Allergies
COMPLETED · NA
-
Viral Mucosal Reprogramming
RECRUITING · Phase 2
-
Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease
ACTIVE NOT RECRUITING · Phase 4
-
Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis
COMPLETED · Phase 3
-
Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.